Status: Recruiting
A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
QRL-101-08 is a multiple ascending dose (MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of a novel formulation of QRL-101 in healthy participants.
Participants needed: 48
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: QurAlis CorporationUpdated: Feb 19, 2026Locations: 1
Eligibility criteria
Age 18 to 65 years of age inclusive at the time of signing the informed consent. [+3]
Currently enrolled in any other clinical trial involving a study drug or off-lab... [+2]